The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Congestive Heart Failure
Interventions
DRUG

Nitric Oxide

40 ppm of Nitric Oxide continuously administered for 48 hours

DRUG

Nitrogen

Nitrogen (N2) administered at 40 ppm for 48 hours

Trial Locations (11)

13353

Deutsches Herfzzentrum Berlin, Augustenburger Platz

15212

Allegheny General Hospital, Pittsburgh

20345

Texas Heart Institute, Houston

27710

Duke University Medical Center, Durham

32545

Herz-und Diabeteszentrum Nordrhein-Westfalen, Gergstrab

44195

Cleveland Clinic Foundation, Cleveland

45219

University of Cincinnati, Cincinnati

75226

Baylor University Medical Center, Dallas

75390

University of Texas/St. Paul Medical Center, Dallas

07112

Newark Beth Isreal Medical Center, Newark

UB96JH

Harefield Hospital, Harefield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY